TipRanks
Advertisement

SMDX - ETF AI Analysis

Compare

Top Page

SMDX

Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX)

Rating:70Neutral
Price Target:―
SMDX, the Intech S&P Small-Mid Cap Diversified Alpha ETF, has a solid overall rating driven by several strong, growing companies with positive outlooks. Key holdings like East West Bancorp, Woodward, United Therapeutics, and Exelixis contribute positively through robust financial performance, bullish or supportive technical trends, and strategic initiatives that support future growth. The rating is held back somewhat by names like HF Sinclair and nVent Electric, where profitability, valuation, and momentum concerns introduce risk, and the fund’s mix of healthcare, financials, industrials, and energy means investors should be aware of sector-specific challenges and regulatory or leverage-related risks.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Broad Sector Diversification
Holdings are spread across many sectors, which helps reduce the impact if any single industry runs into trouble.
Multiple Strong Top Holdings
Several of the largest positions, especially in areas like food distribution, health care, and logistics, have shown strong performance, supporting the fund’s overall results.
Negative Factors
Heavy U.S. Concentration
Almost all assets are invested in U.S. companies, offering very limited geographic diversification.
Mixed Results Among Top Holdings
A few key positions, including a real estate services firm and an engineering company, have shown weak performance, which can drag on returns.
Moderate Expense Ratio
The fund’s fees are not especially low for an ETF, which slightly reduces the net return investors keep over time.

SMDX vs. SPDR S&P 500 ETF (SPY)

SMDX Summary

SMDX is the Intech S&P Small-Mid Cap Diversified Alpha ETF, an actively managed fund that focuses on smaller and mid-sized U.S. companies in the S&P 1000 index. It spreads investments across many sectors, including industrials, technology, finance, and health care. Well-known holdings include Jones Lang LaSalle and United Therapeutics. Investors might consider SMDX for growth potential outside the big, familiar large-cap names and for added diversification in their portfolio. However, because it focuses on smaller companies, the ETF’s price can be more volatile and can go up and down sharply with the market.
How much will it cost me?The expense ratio for the Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized strategy to select stocks with growth potential.
What would affect this ETF?The SMDX ETF, which focuses on small- to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as smaller companies often have higher borrowing costs, or if economic uncertainty impacts consumer spending and industrial activity. Its focus on U.S. markets also makes it sensitive to domestic regulatory changes and geopolitical events.

SMDX Top 10 Holdings

SMDX is leaning into U.S. small- and mid-cap cyclicals, with industrials, financials, and energy quietly steering the ship. HF Sinclair has been a key engine, rising on strong earnings and momentum, while nVent Electric adds another bright spot despite some choppy technical signals. East West Bancorp and Affiliated Managers are more steady contributors, helping balance the ride. On the flip side, Jones Lang LaSalle and United Therapeutics have been lagging lately, modestly dragging on returns. Overall, the fund is broadly diversified across sectors but still very much a U.S.-focused, economically sensitive story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Tenet Healthcare1.25%$1.57M$20.91B28.20%
74
Outperform
Jones Lang Lasalle1.15%$1.44M$14.81B4.57%
79
Outperform
East West Bancorp0.96%$1.20M$17.43B18.90%
79
Outperform
HF Sinclair Corporation0.95%$1.19M$18.99B102.34%
68
Neutral
nVent Electric0.85%$1.06M$26.61B65.98%
76
Outperform
XPO0.80%$1.00M$20.28B38.72%
70
Outperform
Woodward0.78%$983.83K$19.50B32.52%
79
Outperform
Affiliated Managers0.78%$977.56K$9.66B54.20%
74
Outperform
Lamar Advertising0.77%$966.88K$14.62B19.94%
72
Outperform
United Therapeutics0.77%$962.84K$20.39B14.43%
79
Outperform

SMDX Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
26.55
Negative
100DMA
26.40
Negative
200DMA
25.31
Positive
Market Momentum
MACD
-0.31
Positive
RSI
32.97
Neutral
STOCH
1.90
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMDX, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 25.95, equal to the 50-day MA of 26.55, and equal to the 200-day MA of 25.31, indicating a neutral trend. The MACD of -0.31 indicates Positive momentum. The RSI at 32.97 is Neutral, neither overbought nor oversold. The STOCH value of 1.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SMDX.

SMDX Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$124.89M0.35%
70
Neutral
――$749.53M0.75%
68
Neutral
――$691.97M0.62%
64
Neutral
――$495.14M0.75%
69
Neutral
――$291.94M0.55%
68
Neutral
――$199.82M0.68%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
25.45
2.90
12.86%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
RNIN
Bushido Capital US SMID Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement